Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 9, (1588-1601), 10.1007/s00259-017-3728-y)

Publikation: Bidrag til tidsskriftKommentar/debatForskningfagfællebedømt

Standard

Erratum to : Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 9, (1588-1601), 10.1007/s00259-017-3728-y). / Bozkurt, Murat Fani; Virgolini, Irene; Balogova, Sona; Beheshti, Mohsen; Rubello, Domenico; Decristoforo, Clemens; Ambrosini, Valentina; Kjaer, Andreas; Delgado-Bolton, Roberto; Kunikowska, Jolanta; Oyen, Wim J.G.; Chiti, Arturo; Giammarile, Francesco; Sundin, Anders; Fanti, Stefano.

I: European Journal of Nuclear Medicine and Molecular Imaging, Bind 44, Nr. 12, 01.11.2017, s. 2150-2151.

Publikation: Bidrag til tidsskriftKommentar/debatForskningfagfællebedømt

Harvard

Bozkurt, MF, Virgolini, I, Balogova, S, Beheshti, M, Rubello, D, Decristoforo, C, Ambrosini, V, Kjaer, A, Delgado-Bolton, R, Kunikowska, J, Oyen, WJG, Chiti, A, Giammarile, F, Sundin, A & Fanti, S 2017, 'Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 9, (1588-1601), 10.1007/s00259-017-3728-y)', European Journal of Nuclear Medicine and Molecular Imaging, bind 44, nr. 12, s. 2150-2151. https://doi.org/10.1007/s00259-017-3807-0

APA

Bozkurt, M. F., Virgolini, I., Balogova, S., Beheshti, M., Rubello, D., Decristoforo, C., Ambrosini, V., Kjaer, A., Delgado-Bolton, R., Kunikowska, J., Oyen, W. J. G., Chiti, A., Giammarile, F., Sundin, A., & Fanti, S. (2017). Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 9, (1588-1601), 10.1007/s00259-017-3728-y). European Journal of Nuclear Medicine and Molecular Imaging, 44(12), 2150-2151. https://doi.org/10.1007/s00259-017-3807-0

Vancouver

Bozkurt MF, Virgolini I, Balogova S, Beheshti M, Rubello D, Decristoforo C o.a. Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 9, (1588-1601), 10.1007/s00259-017-3728-y). European Journal of Nuclear Medicine and Molecular Imaging. 2017 nov. 1;44(12):2150-2151. https://doi.org/10.1007/s00259-017-3807-0

Author

Bozkurt, Murat Fani ; Virgolini, Irene ; Balogova, Sona ; Beheshti, Mohsen ; Rubello, Domenico ; Decristoforo, Clemens ; Ambrosini, Valentina ; Kjaer, Andreas ; Delgado-Bolton, Roberto ; Kunikowska, Jolanta ; Oyen, Wim J.G. ; Chiti, Arturo ; Giammarile, Francesco ; Sundin, Anders ; Fanti, Stefano. / Erratum to : Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 9, (1588-1601), 10.1007/s00259-017-3728-y). I: European Journal of Nuclear Medicine and Molecular Imaging. 2017 ; Bind 44, Nr. 12. s. 2150-2151.

Bibtex

@article{41f6beb3cbc94a49bda9de8cfe3d6580,
title = "Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 9, (1588-1601), 10.1007/s00259-017-3728-y)",
abstract = "Unfortunately, due to some indeliberate and inadvertent reasons, Professor Anders Sundin{\textquoteright}s name was not included among the authors{\textquoteright} list even though he contributed to the article with all the great efforts and valuable expertise on the field, which all of the authors of this article absolutely agree with and approve that his name should have been among the authors for this article.Professor Sundin contributed to the article with a meticulous review and made valuable additions to the manuscript. Since Professor Sundin is a practising radiologist, his contribution to this guideline was mainly focused on a radiological perspective of PET/CT imaging of neuroendocrine neoplasms and upon his suggestion, some key points from a radiological point of view was added to the manuscript. Professor Sundin{\textquoteright}s scientific contribution to this guideline was really very important and had a great impact given the fact that neuroendocrine tumors are aheterogenous group of neoplasms for which an utmost multidisciplinary approach is definitely warranted. Professor Sundin not only contributed to the article in a scientific way and from a radiologist{\textquoteright}s perspective but he also had a great contribution by means of English-language editing, due to his personal interest in the English language. All of the authors specifically confirm that Professor Sundin was substantially involved in all of the steps during this work. Professor Sundin made substantial contributions to the conception and design of the work; to the acquisition, analysis, and interpretation of data for the work; and to drafting the work and revising it critically for important intellectual content. Therefore, upon his important contribution to this guideline with his great efforts and distinctive expertise in the field, and on behalf of all of the authors and with their approvals, I hereby state that Professor Sundin{\textquoteright}s name should have been among the authors for this article.",
author = "Bozkurt, {Murat Fani} and Irene Virgolini and Sona Balogova and Mohsen Beheshti and Domenico Rubello and Clemens Decristoforo and Valentina Ambrosini and Andreas Kjaer and Roberto Delgado-Bolton and Jolanta Kunikowska and Oyen, {Wim J.G.} and Arturo Chiti and Francesco Giammarile and Anders Sundin and Stefano Fanti",
note = "Publisher Copyright: {\textcopyright} 2017, Springer-Verlag GmbH Germany.",
year = "2017",
month = nov,
day = "1",
doi = "10.1007/s00259-017-3807-0",
language = "English",
volume = "44",
pages = "2150--2151",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer",
number = "12",

}

RIS

TY - JOUR

T1 - Erratum to

T2 - Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 9, (1588-1601), 10.1007/s00259-017-3728-y)

AU - Bozkurt, Murat Fani

AU - Virgolini, Irene

AU - Balogova, Sona

AU - Beheshti, Mohsen

AU - Rubello, Domenico

AU - Decristoforo, Clemens

AU - Ambrosini, Valentina

AU - Kjaer, Andreas

AU - Delgado-Bolton, Roberto

AU - Kunikowska, Jolanta

AU - Oyen, Wim J.G.

AU - Chiti, Arturo

AU - Giammarile, Francesco

AU - Sundin, Anders

AU - Fanti, Stefano

N1 - Publisher Copyright: © 2017, Springer-Verlag GmbH Germany.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Unfortunately, due to some indeliberate and inadvertent reasons, Professor Anders Sundin’s name was not included among the authors’ list even though he contributed to the article with all the great efforts and valuable expertise on the field, which all of the authors of this article absolutely agree with and approve that his name should have been among the authors for this article.Professor Sundin contributed to the article with a meticulous review and made valuable additions to the manuscript. Since Professor Sundin is a practising radiologist, his contribution to this guideline was mainly focused on a radiological perspective of PET/CT imaging of neuroendocrine neoplasms and upon his suggestion, some key points from a radiological point of view was added to the manuscript. Professor Sundin’s scientific contribution to this guideline was really very important and had a great impact given the fact that neuroendocrine tumors are aheterogenous group of neoplasms for which an utmost multidisciplinary approach is definitely warranted. Professor Sundin not only contributed to the article in a scientific way and from a radiologist’s perspective but he also had a great contribution by means of English-language editing, due to his personal interest in the English language. All of the authors specifically confirm that Professor Sundin was substantially involved in all of the steps during this work. Professor Sundin made substantial contributions to the conception and design of the work; to the acquisition, analysis, and interpretation of data for the work; and to drafting the work and revising it critically for important intellectual content. Therefore, upon his important contribution to this guideline with his great efforts and distinctive expertise in the field, and on behalf of all of the authors and with their approvals, I hereby state that Professor Sundin’s name should have been among the authors for this article.

AB - Unfortunately, due to some indeliberate and inadvertent reasons, Professor Anders Sundin’s name was not included among the authors’ list even though he contributed to the article with all the great efforts and valuable expertise on the field, which all of the authors of this article absolutely agree with and approve that his name should have been among the authors for this article.Professor Sundin contributed to the article with a meticulous review and made valuable additions to the manuscript. Since Professor Sundin is a practising radiologist, his contribution to this guideline was mainly focused on a radiological perspective of PET/CT imaging of neuroendocrine neoplasms and upon his suggestion, some key points from a radiological point of view was added to the manuscript. Professor Sundin’s scientific contribution to this guideline was really very important and had a great impact given the fact that neuroendocrine tumors are aheterogenous group of neoplasms for which an utmost multidisciplinary approach is definitely warranted. Professor Sundin not only contributed to the article in a scientific way and from a radiologist’s perspective but he also had a great contribution by means of English-language editing, due to his personal interest in the English language. All of the authors specifically confirm that Professor Sundin was substantially involved in all of the steps during this work. Professor Sundin made substantial contributions to the conception and design of the work; to the acquisition, analysis, and interpretation of data for the work; and to drafting the work and revising it critically for important intellectual content. Therefore, upon his important contribution to this guideline with his great efforts and distinctive expertise in the field, and on behalf of all of the authors and with their approvals, I hereby state that Professor Sundin’s name should have been among the authors for this article.

UR - http://www.scopus.com/inward/record.url?scp=85028599610&partnerID=8YFLogxK

U2 - 10.1007/s00259-017-3807-0

DO - 10.1007/s00259-017-3807-0

M3 - Comment/debate

C2 - 28856372

AN - SCOPUS:85028599610

VL - 44

SP - 2150

EP - 2151

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

SN - 1619-7070

IS - 12

ER -

ID: 283514351